Patents by Inventor Matthew D. Selby

Matthew D. Selby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazole derivatives
    Patent number: 6933312
    Abstract: This invention relates to pyrazole derivatives of formula (I) or pharmaceutically acceptable salts, solvates or derivative thereof, wherein R1 to R4, n W, X and Y are defined in the description, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such the compounds of the present invention are useful in the treatment of a variety of disorders including those in which the inhibition of reverse transcriptase is implicated. Disorders of interest include those caused by Human Immunodificiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS).
    Type: Grant
    Filed: September 23, 2003
    Date of Patent: August 23, 2005
    Assignee: Agouron Pharmaceuticals, Inc.
    Inventors: David A. Price, Matthew D. Selby, Paul A. Stupple
  • Pyrazole derivatives
    Publication number: 20040133002
    Abstract: This invention relates to pyrazole derivatives of formula (I) 1
    Type: Application
    Filed: September 23, 2003
    Publication date: July 8, 2004
    Applicant: Pfizer, Inc.
    Inventors: David A. Price, Matthew D. Selby, Paul A. Stupple